國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Pharmacology and therapeutics of ast...

Barnes, Peter J.

Pharmacology and therapeutics of asthma and COPD

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Pharmacology and therapeutics of asthma and COPDedited by Clive P. Page, Peter J. Barnes.
其他題名:	Pharmacology and therapeutics of asthma and chronic obstructive pulmonary disease
其他作者:	Page, Clive P.
出版者:	Cham :Springer International Publishing :2017.
面頁冊數:	x, 285 p. :ill., digital ;24 cm.
Contained By:	Springer eBooks
標題:	AsthmaChemotherapy.
電子資源:	http://dx.doi.org/10.1007/978-3-319-52175-6
ISBN:	9783319521756$q(electronic bk.)

Pharmacology and therapeutics of asthma and COPD
Pharmacology and therapeutics of asthma and COPD[electronic resource] /Pharmacology and therapeutics of asthma and chronic obstructive pulmonary diseaseedited by Clive P. Page, Peter J. Barnes. - Cham :Springer International Publishing :2017. - x, 285 p. :ill., digital ;24 cm. - Handbook of experimental pharmacology,v.2370171-2004 ;. - Handbook of experimental pharmacology ;208..

Pathogenesis of bronchial asthma and chronic obstructive pulmonary disease - common diseases with unmet needs -- Beta 2 agonists -- Muscarinic receptor antagonists -- Xanthines and Phosphodiesterase inhibitors -- Glucocorticosteroids -- Fixed dose combination inhalers -- Anti-IgE and biologic approaches for the treatment of asthma -- Leukotriene receptor antagonists and anti-allergy drugs -- Novel anti-inflammatory drugs -- Bifunctional drugs for the treatment of respiratory diseases -- Drugs affecting TRP channels -- Evaluation of new drugs for asthma and COPD: endpoints, biomarkers and clinical trial design -- Drug delivery devices for inhaled medicines.

The present volume is supposed to be a major reference resource for chest physicians and those involved in the development of novel pharmaceutical entities for these diseases. Internationally recognized authorities review the most important new information on the advances in our understanding of the pathogenesis and treatment of these diseases, including the substantial advances in the topical delivery of inhaled medicines. Each chapter is extensively referenced, generously illustrated with clear diagrams and photographs, and represents a state-of-the-art review of this important area of respiratory medicine.

ISBN: 9783319521756$q(electronic bk.)

Standard No.: 10.1007/978-3-319-52175-6doiSubjects--Topical Terms:

569462
Asthma
--Chemotherapy.

LC Class. No.: RC591

Dewey Class. No.: 616.238

Pharmacology and therapeutics of asthma and COPD
LDR:02402nmm a2200337 a 4500 001 507122
003 DE-He213
005 20170206162855.0
006 m d
007 cr nn 008maaau
008 171030s2017 gw s 0 eng d
020 $a 9783319521756$q(electronic bk.)
020 $a 9783319521732$q(paper)
024 7 $a 10.1007/978-3-319-52175-6 $2 doi
035 $a 978-3-319-52175-6
040 $a GP $c GP
041 0 $a eng
050 4 $a RC591
072 7 $a MMG $2 bicssc
072 7 $a MED071000 $2 bisacsh
082 0 4 $a 616.238 $2 23
090 $a RC591 $b .P536 2017
245 0 0 $a Pharmacology and therapeutics of asthma and COPD $h [electronic resource] / $c edited by Clive P. Page, Peter J. Barnes.
246 3 $a Pharmacology and therapeutics of asthma and chronic obstructive pulmonary disease
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2017.
300 $a x, 285 p. : $b ill., digital ; $c 24 cm.
490 1 $a Handbook of experimental pharmacology, $x 0171-2004 ; $v v.237
505 0 $a Pathogenesis of bronchial asthma and chronic obstructive pulmonary disease - common diseases with unmet needs -- Beta 2 agonists -- Muscarinic receptor antagonists -- Xanthines and Phosphodiesterase inhibitors -- Glucocorticosteroids -- Fixed dose combination inhalers -- Anti-IgE and biologic approaches for the treatment of asthma -- Leukotriene receptor antagonists and anti-allergy drugs -- Novel anti-inflammatory drugs -- Bifunctional drugs for the treatment of respiratory diseases -- Drugs affecting TRP channels -- Evaluation of new drugs for asthma and COPD: endpoints, biomarkers and clinical trial design -- Drug delivery devices for inhaled medicines.
520 $a The present volume is supposed to be a major reference resource for chest physicians and those involved in the development of novel pharmaceutical entities for these diseases. Internationally recognized authorities review the most important new information on the advances in our understanding of the pathogenesis and treatment of these diseases, including the substantial advances in the topical delivery of inhaled medicines. Each chapter is extensively referenced, generously illustrated with clear diagrams and photographs, and represents a state-of-the-art review of this important area of respiratory medicine.
650 0 $a Asthma $x Chemotherapy. $3 569462
650 0 $a Lungs $x Diseases, Obstructive $x Chemotherapy. $3 301714
650 0 $a Antiasthmatic agents. $3 569463
650 1 4 $a Biomedicine. $3 273648
650 2 4 $a Pharmacology/Toxicology. $3 273652
650 2 4 $a Pneumology/Respiratory System. $3 274253
650 2 4 $a Dermatology. $3 274951
700 1 $a Page, Clive P. $3 563220
700 1 $a Barnes, Peter J. $3 773617
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
830 0 $a Handbook of experimental pharmacology ; $v 208. $3 559421
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-52175-6
950 $a Biomedical and Life Sciences (Springer-11642)